MCA -maybe mesenchymal cells from autologous sources - so specifically ipscs where the four factors involved in doing the induction of pluripotency are applied to an autologous source and what is then done is that the ipscs are directed towards a mesenchymal fate --- is that what is going on there ?
- Forums
- ASX - By Stock
- CYP
- The Phase I/IIb Nereid Study Is Now Registered
CYP
cynata therapeutics limited
Add to My Watchlist
9.09%
!
18.0¢

The Phase I/IIb Nereid Study Is Now Registered, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $40.67M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $29.91K | 170.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 27622 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 0.175 |
1 | 62866 | 0.170 |
2 | 60542 | 0.165 |
2 | 27975 | 0.160 |
3 | 181290 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 27622 | 2 |
0.185 | 135916 | 3 |
0.190 | 66916 | 2 |
0.195 | 9659 | 3 |
0.200 | 55400 | 2 |
Last trade - 15.57pm 28/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |